Indirect Comparison of the Efficacy Between Topotecan and Other Treatments for Recurrent Carcinoma of the Cervix
N/A
21 Years
N/A
21 Years
N/A
Not Enrolling
Female
Cervical Intraepithelial Neoplasia
Female
Cervical Intraepithelial Neoplasia
Trial Information
Indirect Comparison of the Efficacy Between Topotecan and Other Treatments for Recurrent Carcinoma of the Cervix
Inclusion Criteria:
- randomised clinical trials, or systematic reviews and meta-analyses
- treatment with topotecan or platinum-based single and combination regimens in female
patients of any race with cancer of the cervix recurrent after radiotherapy or stage
IVB disease
Exclusion Criteria:
- None
Type of Study:
Observational
Study Design:
Time Perspective: Retrospective
Outcome Measure:
Overall survival
Outcome Time Frame:
12 months
Safety Issue:
No
Principal Investigator
GSK Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
GlaxoSmithKline
Authority:
United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study ID:
114016
NCT ID:
NCT01345279
Start Date:
June 2009
Completion Date:
July 2009
Related Keywords:
- Cervical Intraepithelial Neoplasia
- Neoplasms
- Carcinoma
- Cervical Intraepithelial Neoplasia
- Carcinoma in Situ
Name | Location |
|---|
